Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study.

Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, Faber J, Hansen PR, Pedersen OD, Torp-Pedersen C, Gislason GH.

BMJ. 2012 Nov 27;345:e7895. doi: 10.1136/bmj.e7895.

2.

Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.

Selmer C, Olesen JB, Hansen ML, von Kappelgaard LM, Madsen JC, Hansen PR, Pedersen OD, Faber J, Torp-Pedersen C, Gislason GH.

J Clin Endocrinol Metab. 2014 Jul;99(7):2372-82. doi: 10.1210/jc.2013-4184. Epub 2014 Mar 21.

PMID:
24654753
3.

Thyroid status, cardiovascular risk, and mortality in older adults.

Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW.

JAMA. 2006 Mar 1;295(9):1033-41.

4.

How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators.

Krahn AD, Klein GJ, Kerr CR, Boone J, Sheldon R, Green M, Talajic M, Wang X, Connolly S.

Arch Intern Med. 1996 Oct 28;156(19):2221-4.

PMID:
8885821
5.

Cardiovascular events in thyroid disease: a population based, prospective study.

Schultz M, Kistorp C, Raymond I, Dimsits J, Tuxen C, Hildebrandt P, Faber J.

Horm Metab Res. 2011 Aug;43(9):653-9. doi: 10.1055/s-0031-1283162. Epub 2011 Aug 5.

PMID:
21823062
6.

Risk assessment in the development of atrial fibrillation at patients with associate thyroid dysfunctions.

Tănase DM, Ionescu SD, Ouatu A, Ambăruş V, Arsenescu-Georgescu C.

Rev Med Chir Soc Med Nat Iasi. 2013 Jul-Sep;117(3):623-9.

PMID:
24502026
7.

Association between serum free thyroxine concentration and atrial fibrillation.

Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, Sheppard MC, Franklyn JA.

Arch Intern Med. 2007 May 14;167(9):928-34.

PMID:
17502534
8.

Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk.

Nanchen D, Gussekloo J, Westendorp RG, Stott DJ, Jukema JW, Trompet S, Ford I, Welsh P, Sattar N, Macfarlane PW, Mooijaart SP, Rodondi N, de Craen AJ; PROSPER Group.

J Clin Endocrinol Metab. 2012 Mar;97(3):852-61. doi: 10.1210/jc.2011-1978. Epub 2012 Jan 11.

PMID:
22238391
9.

High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study.

Heeringa J, Hoogendoorn EH, van der Deure WM, Hofman A, Peeters RP, Hop WC, den Heijer M, Visser TJ, Witteman JC.

Arch Intern Med. 2008 Nov 10;168(20):2219-24. doi: 10.1001/archinte.168.20.2219.

PMID:
19001198
10.

New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study.

Selmer C, Hansen ML, Olesen JB, Mérie C, Lindhardsen J, Olsen AM, Madsen JC, Schmidt U, Faber J, Hansen PR, Pedersen OD, Torp-Pedersen C, Gislason GH.

PLoS One. 2013;8(2):e57893. doi: 10.1371/journal.pone.0057893. Epub 2013 Feb 28.

12.

The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.

Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, et al.

Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68.

PMID:
7641412
13.

[Is there a need for treatment in subclinical hypo- and hyperthyroidism?].

Lerch M, Meier C, Staub JJ.

Ther Umsch. 1999 Jul;56(7):369-73. Review. German.

PMID:
10434773
14.

Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.

Batcher EL, Tang XC, Singh BN, Singh SN, Reda DJ, Hershman JM; SAFE-T Investigators.

Am J Med. 2007 Oct;120(10):880-5.

PMID:
17904459
15.

Cardiovascular disease and thyroid function.

Faber J, Selmer C.

Front Horm Res. 2014;43:45-56. doi: 10.1159/000360558. Epub 2014 Jun 10.

PMID:
24943297
16.

Subclinical hyperthyroidism as a risk factor for atrial fibrillation.

Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B.

Am Heart J. 2001 Nov;142(5):838-42.

PMID:
11685172
17.

Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED.

Buccelletti F, Carroccia A, Marsiliani D, Gilardi E, Silveri NG, Franceschi F.

Am J Emerg Med. 2011 Nov;29(9):1158-62. doi: 10.1016/j.ajem.2010.06.010. Epub 2010 Aug 13.

PMID:
20708873
18.

Thyroid diseases and cerebrovascular disease.

Squizzato A, Gerdes VE, Brandjes DP, Büller HR, Stam J.

Stroke. 2005 Oct;36(10):2302-10. Epub 2005 Sep 22. Review.

19.

Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies.

Gencer B, Collet TH, Virgini V, Auer R, Rodondi N.

Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):4-12. Review.

PMID:
23369133
20.

Subclinical thyroid dysfunction and blood pressure: a community-based study.

Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V.

Clin Endocrinol (Oxf). 2006 Oct;65(4):486-91.

PMID:
16984241

Supplemental Content

Support Center